{"entity":{"type":"insider","cik":"0001283305","url":"/insider/0001283305","json_url":"/insider/0001283305.json","name":"YAROSHEVSKY GLANVILLE MARY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":3,"first":"2006-01-11","last":"2006-05-09","span_basis":"filed_date"},"name_variants":[{"name":"YAROSHEVSKY GLANVILLE MARY","source":"filing","n_filings":3,"first_seen":"2006-01-11","last_seen":"2006-05-09"}],"transactions":[{"id":5425156,"accession":"0001209191-06-028769","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-06-028769","line_url":"/filing/0001209191-06-028769","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283305","owner_name":"YAROSHEVSKY GLANVILLE MARY","owner_display_name":"YAROSHEVSKY GLANVILLE MARY","owner_url":"/insider/0001283305","role":"Officer (Vice President, Human Capital)","role_mark":"O","role_mark_label":"Officer (Vice President, Human Capital)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Human Capital","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":12.497333333333334,"price_display":"12.50","price_state":"stated","total_value":18746.0,"total_display":"18,746.00","total_whole":"18,746","shares_owned_after":1100.0,"shares_owned_after_display":"1,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-08","filed_date":"2006-05-09","scope":"insider","n_lines":7},{"id":3906503,"accession":"0001209191-06-016383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-016383","line_url":"/filing/0001209191-06-016383#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283305","owner_name":"YAROSHEVSKY GLANVILLE MARY","owner_display_name":"YAROSHEVSKY GLANVILLE MARY","owner_url":"/insider/0001283305","role":"Officer (Vice President, Human Capital)","role_mark":"O","role_mark_label":"Officer (Vice President, Human Capital)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Human Capital","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1115.0,"shares_display":"1,115","price_per_share":14.72,"price_display":"14.72","price_state":"stated","total_value":16412.8,"total_display":"16,412.80","total_whole":"16,413","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-07","filed_date":"2006-03-08","scope":"insider"},{"id":3156534,"accession":"0001209191-06-003143","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-06-003143","line_url":"/filing/0001209191-06-003143","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283305","owner_name":"YAROSHEVSKY GLANVILLE MARY","owner_display_name":"YAROSHEVSKY GLANVILLE MARY","owner_url":"/insider/0001283305","role":"Officer (Vice President, Human Capital)","role_mark":"O","role_mark_label":"Officer (Vice President, Human Capital)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President, Human Capital","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3681.0,"shares_display":"3,681","price_per_share":10.14607715294757,"price_display":"10.15","price_state":"stated","total_value":37347.71,"total_display":"37,347.71","total_whole":"37,348","shares_owned_after":2896.0,"shares_owned_after_display":"2,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-09","filed_date":"2006-01-11","scope":"insider","n_lines":11}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001128495","name":"ANADYS PHARMACEUTICALS INC","url":"/issuer/0001128495","role":"Officer (Vice President, Human Capital)","n_filings":3,"first_seen":"2006-01-11","last_seen":"2006-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283305","retrieved_at":"2026-08-22T15:32:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}